MeSH tree: D23.050.301.500
Researchers at the UCLA Jonsson Comprehensive Cancer Center have found certain immune cells can still fight cancer even when the cancer cells lack an important protein that the immune system relies on to help track down cancer ...
Nov 28, 2023
0
74
Researchers from Skoltech contributed to a large study made by colleagues from Pirogov Russian National Research Medical University, Shemyakin-Ovchinnikov Institute of bioorganic chemistry and other universities and organizations. ...
Nov 27, 2023
0
71
Conventional wisdom lays out two major roles for the major histocompatibility complex (MHC): Class I MHC (MHC-I) displays peptide fragments of proteins from within the cell on the cell surface and elicits a response from ...
Oct 12, 2023
0
79
A recent study found new ways to identify mismatches between donors and recipients in kidney transplantation.
Oct 6, 2023
0
65
A broad new strategy could hold hope for treating virtually all blood cancers with CAR T cell therapy, which is currently approved for five subtypes of blood cancer. Scientists in the Perelman School of Medicine at the University ...
Aug 31, 2023
0
58
An obscure class of molecules, part of the vast system that helps the human body distinguish "self" from "non-self," may also hold the key to stopping SARS-CoV-2 from commandeering healthy cells, scientists have found in ...
In the U.S., 17 people die every day while waiting for an organ transplant. Dr. Shennen Mao, a Mayo Clinic transplant surgeon, says having a diverse pool of organ donors will help serve a growing wait list of those in need.
Aug 16, 2023
0
26
People who contract COVID-19 but never develop symptoms—the so-called super dodgers—may have a genetic ace up their sleeve. They're more than twice as likely as those who become symptomatic to carry a specific gene variation ...
Jul 19, 2023
0
58
Patients recovering from a severe spinal-cord injury can develop an immune deficiency that puts them at risk of developing life-threatening infections, according to a new study by researchers at The Ohio State University ...
Jun 30, 2023
0
45
Researchers at the University of Houston are working to make T-cell immunotherapy safer, developing a tool called CrossDome, which uses a combination of genetic and biochemical information to predict if T-cell immunotherapies ...
Jun 14, 2023
0
46
